Colonoscopic surveillance in long-standing total ulcerative colitis—A 15-year follow-up studyRobert Löfberg, Åke Öst, Olle Broström et al.|Gastroenterology|1990Cited by 197
A Randomized Controlled Trial of the Efficacy and Safety of CCX282-B, an Orally-Administered Blocker of Chemokine Receptor CCR9, for Patients with Crohn’s DiseaseSatish Keshav, Tomáš Vaňásek, Yaron Niv et al.|PLoS ONE|2013Cited by 134
DNA aneuploidy in ulcerative colitis: Reproducibility, topographic distribution, and relation to dysplasiaRobert Löfberg, Bernhard Tribukait, Olle Broström et al.|Gastroenterology|1992Cited by 117
Sialyl-Tn antigen as a marker of colon cancer risk in ulcerative colitis: Relation to dysplasia and DNA aneuploidyPer Karlén, Steven H. Itzkowitz, E. T. Young et al.|Gastroenterology|1998Cited by 73